Why the study?
What novel proteins are released by thrombin-activated human platelets, and do they localize to atherosclerotic lesions?
Population
Human platelets and human atherosclerotic lesions
Comparison
Thrombin activation (in vitro proteomics approach) vs Normal vasculature (for tissue localization)
Design
Preclinical
Authors
Loading...
May offer novel atherosclerosis targets; animal data leave open clinical translation pending human studies.
What novel proteins are released by thrombin-activated human platelets, and do they localize to atherosclerotic lesions?
The identification of novel proteins released by activated platelets that localize to atherosclerotic lesions provides potential new therapeutic targets for atherosclerosis and thrombosis.
Coppinger et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: